Editorial Comment on “Efficacy and safety of dose‐dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle‐invasive bladder cancer”

Abstract

on "Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer" is hoped that the efficacy of this regimen will continue to be demonstrated and that it will be established as an effective treatment option for patients.